对于获得的酸盐激酶缺乏症的治疗方法
1Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Pediatric blood & cancer
|November 14, 2024
概括
米塔皮瓦特有效地治疗获得的酸盐激酶缺乏症,这是严重血液溶解性贫血的罕见原因. 这份病例报告表明,mitapivat可以消除输血依赖,改善患者的生活质量.
科学领域:
- 血液学 血液学 血液学
- 酶学 是一种酶学.
- 遗传学 遗传学 是一个
背景情况:
- 酸盐激酶 (PK) 缺乏可以导致先天性血液溶解性贫血症.
- 获得的PK缺乏症与髓状腺疾病和严重贫血有关.
- 获得的PK缺陷缺乏向治疗.
研究的目的:
- 报告mitapivat在获得的PK缺乏症患者中的新用途.
- 评估mitapivat在解决输血依赖方面的有效性.
- 评估mitapivat对症状和生活质量的影响.
主要方法:
- 一个患有获得的PK缺陷的患者的病例报告.
- 治疗方法是使用mitapivat.
- 监测输血需求,贫血严重程度和生活质量.
主要成果:
- 米塔皮瓦特治疗导致红细胞输血停止.
- 观察到患者症状和生活质量的显著改善.
- 血溶性贫血的明显改善得到了实现.
结论:
- 米塔皮瓦特是一种潜在的治疗选择,用于获得的PK缺乏症.
- 这一案例证明了对输血依赖性贫血的成功管理.
- 米塔皮瓦特为以前无法治疗的疾病提供了有前途的治疗方法.
相关概念视频
Inborn Errors of Metabolism
131
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
131
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


